Granulocyte colony-stimulating factor therapy for facioscapulohumeral dystrophy: a case report

Journal Title: Progress in Health Sciences - Year 2016, Vol 6, Issue 2

Abstract

We examined the safety and effectiveness of a low dose of analog granulocyte-colony stimulating factor in a 15-year-old boy with facioscapulohumeral dystrophy. The onset of disease was noted at 12 years of age. The physical examination noted general muscle atrophy more pronounced at left side of the body. He was able to walk 300 meters within 6 minute walk test. Granulocyte colony-stimulating factor 5 μg/kg was given subcutaneously daily for 5 days/month for 1, 2, 3, 6 and 12 months. Clinical examination, laboratory tests including blood, biochemical tests, and CD34+ cells were performed. A significant increase of muscle strength in the lower and upper limbs between baseline, and after 3 months of treatment, after 6, and after 12 months was found. He was able to walk 480 meters within 6 minutes after 12 months. Electromyography demonstrated increase of amplitude in the examined in upper and lower limbs after six months compared to baseline. Leukocyte levels remained below 25000/μL. CD34+ increased significantly at day 5 of granulocyte colony-stimulating factor admini-stration. It was safe and well tolerated by the patient. A significant increase in muscle strength in this patient with facioscapulohumeral dystrophy after 3 months of treatment, after 6, and after 12 months since the first treatment course was completed may indicate beneficial effects of granulocyte colony-stimulating factor in this disorder.

Authors and Affiliations

D. Sienkiewicz, W. Kułak, B. Okurowska-Zawada, G. Paszko-Patej, J. Wojtkowski, E. Dmitruk, K. Okulczyk, A. Kalinowska, R. Pogorzelski

Keywords

Related Articles

Services Provided by Drop in Centre (DIC) to Patient Living with HIV/AIDS in a Tertiary Health Care Centre in Mumbai

Purpose: To assess the role of drop in centre in providing assistance to Patients Living with HIV/AIDS (PLHA). Materials and methods: A cross-sectional descriptive study was conducted at a...

Functional appliances: The activator and the functional regulator- A review

n this review of literature we are discussing the effects of functional appliances on the dentofacial structures in the treatment of Class II malocclusions. Despite recent questions on the effectiveness of early treatmen...

Nutrition and peritoneal dialysis patients – a review

Introduction: The Peritoneal Dialysis (PD) is a preferable treatment option of the renal replacement in patients with chronic renal failure (CRF) end stage. Purpose: The purpose of this study was to review of articles...

CXCR4+ and CCR5+ expression on blood lymphocytes and its changes in AIDS development in HIV/HCV coinfected patients

Purpose: To measure the CCR5+ and CXCR4+ expression on blood lymphocytes, its changes in AIDS development, and correlation of CCR5+ and CXCR4+ expression with a number of T-cells, T-helpers, cytotoxic T-cells, activated...

Application of Helicobacter pylori antigen test to evaluate gastric mucosa specimens

Purpose: To investigate, whether the test documenting the presence of Helicobacter pylori (H. pylori) antigens in the gastric mucosa may be used as diagnostic test. Materials and methods: Mucosal specimens taken from e...

Download PDF file
  • EP ID EP186967
  • DOI 10.5604/01.3001.0009.5165
  • Views 105
  • Downloads 0

How To Cite

D. Sienkiewicz, W. Kułak, B. Okurowska-Zawada, G. Paszko-Patej, J. Wojtkowski, E. Dmitruk, K. Okulczyk, A. Kalinowska, R. Pogorzelski (2016). Granulocyte colony-stimulating factor therapy for facioscapulohumeral dystrophy: a case report. Progress in Health Sciences, 6(2), 175-177. https://europub.co.uk/articles/-A-186967